2026.04.15
Avance QQ Collagen published in the Journal of Cosmetic Dermatology
We are proud to share that the clinical study on Avance QQ Collagen has been officially published in the Journal of Cosmetic Dermatology, highlighting its observed benefits on skin health and appearance. This is a meaningful brand milestone that speaks to our commitment to science-backed innovation.
The study examined the role of Liposomal Encapsulated Technology in enhancing the delivery and efficacy of collagen tripeptides for enhanced skin structure, elasticity and radiance. What sets this journal apart is its focus on not just ingredients, but on how delivery technology works together with the formulation to enhance efficacy.
Over 8 weeks, 75 healthy adults aged 25 to 65 who consumed either a placebo, a collagen tripeptide formulation without liposomal delivery or a collagen tripeptide formulation with liposomal delivery – QQ Collagen. Visible results were observed from Week 2, with improvements in skin brightness, elasticity, hydration and the appearance of facial wrinkles recorded by Week 4.
Our commitment goes beyond just the label. By validating the effectiveness of the complete formation, we hold science to the highest standard. This publication is a reflection of Avance's commitment to developing innovative health supplements that are supported by clinical evidence and designed to deliver visible results.